2024 Q2 Form 10-Q Financial Statement

#000173994024000015 Filed on May 02, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $60.52B $57.26B
YoY Change 24.57% 23.08%
Cost Of Revenue $44.49B $41.43B
YoY Change 4.75% 31.7%
Gross Profit $16.03B $15.82B
YoY Change 162.37% 5.09%
Gross Profit Margin 26.49% 27.64%
Selling, General & Admin $3.684B $3.705B
YoY Change 7.28% 4.72%
% of Gross Profit 22.98% 23.41%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $738.0M $741.0M
YoY Change -2.25% -1.07%
% of Gross Profit 4.6% 4.68%
Operating Expenses $3.684B $3.705B
YoY Change -5.27% 4.72%
Operating Profit $2.412B $2.256B
YoY Change 8.6% 11.96%
Interest Expense -$423.0M -$2.158B
YoY Change 25.52% 502.79%
% of Operating Profit -17.54% -95.66%
Other Income/Expense, Net -$375.0M -$322.0M
YoY Change 3.31% -10.06%
Pretax Income $1.989B $79.00M
YoY Change 5.57% -95.07%
Income Tax $360.0M $291.0M
% Of Pretax Income 18.1% 368.35%
Net Earnings $1.629B -$212.0M
YoY Change 11.58% -116.23%
Net Earnings / Revenue 2.69% -0.37%
Basic Earnings Per Share $5.51 -$0.97
Diluted Earnings Per Share $5.45 -$0.97
COMMON SHARES
Basic Shares Outstanding 284.1M shares 292.4M shares
Diluted Shares Outstanding 284.1M shares 286.5M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.856B $9.547B
YoY Change -24.87% 7.89%
Cash & Equivalents $6.788B $8.439B
Short-Term Investments $1.068B $1.108B
Other Short-Term Assets $2.664B $2.263B
YoY Change 89.34% 79.18%
Inventory $5.173B $4.630B
Prepaid Expenses
Receivables $25.11B $20.56B
Other Receivables $0.00 $0.00
Total Short-Term Assets $46.22B $43.36B
YoY Change 33.14% 35.38%
LONG-TERM ASSETS
Property, Plant & Equipment $3.551B $3.607B
YoY Change -8.57% -5.99%
Goodwill $44.26B $44.26B
YoY Change -3.39% -3.39%
Intangibles $30.18B $30.49B
YoY Change -4.85% -5.02%
Long-Term Investments $15.94B $16.03B
YoY Change -15.94% -19.57%
Other Assets $3.276B $3.293B
YoY Change -78.11% 28.48%
Total Long-Term Assets $109.2B $109.8B
YoY Change -5.3% -5.34%
TOTAL ASSETS
Total Short-Term Assets $46.22B $43.36B
Total Long-Term Assets $109.2B $109.8B
Total Assets $155.4B $153.1B
YoY Change 3.59% 3.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.275B $8.118B
YoY Change 14.9% 10.3%
Accrued Expenses $9.003B $8.857B
YoY Change 5.93% -3.46%
Deferred Revenue
YoY Change
Short-Term Debt $790.0M $884.0M
YoY Change
Long-Term Debt Due $927.0M $831.0M
YoY Change -79.93% -75.69%
Total Short-Term Liabilities $55.37B $51.98B
YoY Change 16.96% 16.21%
LONG-TERM LIABILITIES
Long-Term Debt $30.18B $31.05B
YoY Change 7.33% 6.62%
Other Long-Term Liabilities $3.538B $3.653B
YoY Change -83.52% 35.7%
Total Long-Term Liabilities $3.538B $3.653B
YoY Change -92.87% 35.7%
TOTAL LIABILITIES
Total Short-Term Liabilities $55.37B $51.98B
Total Long-Term Liabilities $3.538B $3.653B
Total Liabilities $113.9B $111.8B
YoY Change 8.9% 8.11%
SHAREHOLDERS EQUITY
Retained Earnings $42.13B $40.98B
YoY Change 5.5% 5.5%
Common Stock $31.05B $30.30B
YoY Change 2.01% -0.13%
Preferred Stock
YoY Change
Treasury Stock (at cost) $29.41B $27.77B
YoY Change 27.58% 21.23%
Treasury Stock Shares
Shareholders Equity $41.33B $41.18B
YoY Change
Total Liabilities & Shareholders Equity $155.4B $153.1B
YoY Change 3.59% 3.48%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $1.629B -$212.0M
YoY Change 11.58% -116.23%
Depreciation, Depletion And Amortization $738.0M $741.0M
YoY Change -2.25% -1.07%
Cash From Operating Activities $265.0M $4.840B
YoY Change -89.37% -3.74%
INVESTING ACTIVITIES
Capital Expenditures $370.0M $300.0M
YoY Change -6.8% -26.47%
Acquisitions
YoY Change
Other Investing Activities -$270.0M $112.0M
YoY Change 1488.24% 160.47%
Cash From Investing Activities -$640.0M -$495.0M
YoY Change 54.59% -83.41%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $2.210B
YoY Change 2662.5%
Cash From Financing Activities -2.309B -$2.529B
YoY Change 430.8% 6735.14%
NET CHANGE
Cash From Operating Activities 265.0M $4.840B
Cash From Investing Activities -640.0M -$495.0M
Cash From Financing Activities -2.309B -$2.529B
Net Change In Cash -2.684B $1.807B
YoY Change -263.36% -10.23%
FREE CASH FLOW
Cash From Operating Activities $265.0M $4.840B
Capital Expenditures $370.0M $300.0M
Free Cash Flow -$105.0M $4.540B
YoY Change -105.01% -1.73%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
44688000000 usd
CY2024Q1 us-gaap Supplier Finance Program Obligation Current Statement Of Financial Position Extensible Enumeration
SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#AccountsPayableCurrent
CY2023Q4 us-gaap Supplier Finance Program Obligation Current Statement Of Financial Position Extensible Enumeration
SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#AccountsPayableCurrent
CY2024Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
usd
CY2023 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
usd
CY2023 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
usd
CY2023 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
usd
CY2023Q1 ci Realized Investment Losses Commercial Mortgage Loans Real Estate Entities Certain Equity Securities With No Readily Determinable Fair Value
RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecuritiesWithNoReadilyDeterminableFairValue
usd
CY2024Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
usd
CY2023Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
usd
CY2024Q1 us-gaap Premiums Earned Net
PremiumsEarnedNet
11603000000 usd
CY2023Q1 us-gaap Premiums Earned Net
PremiumsEarnedNet
11025000000 usd
CY2024Q1 us-gaap Net Investment Income
NetInvestmentIncome
290000000 usd
CY2023Q1 us-gaap Net Investment Income
NetInvestmentIncome
277000000 usd
CY2024Q1 us-gaap Revenues
Revenues
57255000000 usd
CY2023Q1 us-gaap Revenues
Revenues
46517000000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
41431000000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
31459000000 usd
CY2024Q1 us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
9440000000 usd
CY2023Q1 us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
9046000000 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3705000000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3538000000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
423000000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
459000000 usd
CY2024Q1 us-gaap Benefits Losses And Expenses
BenefitsLossesAndExpenses
54999000000 usd
CY2023Q1 us-gaap Benefits Losses And Expenses
BenefitsLossesAndExpenses
44502000000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2256000000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2015000000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-322000000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-358000000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-19000000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 usd
CY2024Q1 ci Realized Investment Gain Loss
RealizedInvestmentGainLoss
-1836000000 usd
CY2023Q1 ci Realized Investment Gain Loss
RealizedInvestmentGainLoss
-56000000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
79000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1601000000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
291000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
295000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-212000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1306000000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
65000000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
39000000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-277000000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1267000000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.97
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.28
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.97
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.24
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-212000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1306000000 usd
CY2024Q1 ci Other Comprehensive Income Loss Available For Sale Securities And Derivatives Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax
121000000 usd
CY2023Q1 ci Other Comprehensive Income Loss Available For Sale Securities And Derivatives Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax
194000000 usd
CY2024Q1 ci Oci Liability For Future Policy Benefit And Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Reclassification Adjustment And Tax Portion Attributable To Parent
OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTaxPortionAttributableToParent
-560000000 usd
CY2023Q1 ci Oci Liability For Future Policy Benefit And Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Reclassification Adjustment And Tax Portion Attributable To Parent
OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTaxPortionAttributableToParent
-331000000 usd
CY2024Q1 ci Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax Including Temporary Equity
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity
-26000000 usd
CY2023Q1 ci Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax Including Temporary Equity
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity
16000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-5000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-10000000 usd
CY2024Q1 ci Other Comprehensive Income Loss Net Of Tax Including Temporary Equity
OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity
-460000000 usd
CY2023Q1 ci Other Comprehensive Income Loss Net Of Tax Including Temporary Equity
OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity
-111000000 usd
CY2024Q1 ci Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Including Temporary Equity
ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity
-672000000 usd
CY2023Q1 ci Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Including Temporary Equity
ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity
1195000000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
0 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
34000000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
65000000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
5000000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
65000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
39000000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-737000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1156000000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8439000000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7822000000 usd
CY2024Q1 us-gaap Short Term Investments
ShortTermInvestments
1108000000 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
925000000 usd
CY2024Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
20563000000 usd
CY2023Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
17722000000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
4630000000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
5645000000 usd
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
2263000000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2169000000 usd
CY2024Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
6354000000 usd
CY2023Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
3068000000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
43357000000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
37351000000 usd
CY2024Q1 us-gaap Long Term Investments
LongTermInvestments
16025000000 usd
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
17985000000 usd
CY2024Q1 ci Reinsurance Recoverables Non Current
ReinsuranceRecoverablesNonCurrent
4672000000 usd
CY2023Q4 ci Reinsurance Recoverables Non Current
ReinsuranceRecoverablesNonCurrent
4835000000 usd
CY2024Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
3607000000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
3695000000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
44258000000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
44259000000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
30491000000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
30863000000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3293000000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3421000000 usd
CY2024Q1 us-gaap Separate Account Assets
SeparateAccountAssets
7416000000 usd
CY2023Q4 us-gaap Separate Account Assets
SeparateAccountAssets
7430000000 usd
CY2024Q1 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
0 usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
2922000000 usd
CY2024Q1 us-gaap Assets
Assets
153119000000 usd
CY2023Q4 us-gaap Assets
Assets
152761000000 usd
CY2024Q1 ci Insurance And Contractholder Liabilities Current
InsuranceAndContractholderLiabilitiesCurrent
5788000000 usd
CY2023Q4 ci Insurance And Contractholder Liabilities Current
InsuranceAndContractholderLiabilitiesCurrent
5514000000 usd
CY2024Q1 ci Pharmacy And Service Costs Payable
PharmacyAndServiceCostsPayable
24284000000 usd
CY2023Q4 ci Pharmacy And Service Costs Payable
PharmacyAndServiceCostsPayable
19815000000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
8118000000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8553000000 usd
CY2024Q1 ci Accrued Expenses And Other Liabilities
AccruedExpensesAndOtherLiabilities
8857000000 usd
CY2023Q4 ci Accrued Expenses And Other Liabilities
AccruedExpensesAndOtherLiabilities
9955000000 usd
CY2024Q1 us-gaap Debt Current
DebtCurrent
1715000000 usd
CY2023Q4 us-gaap Debt Current
DebtCurrent
2775000000 usd
CY2024Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
3215000000 usd
CY2023Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
2104000000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
51977000000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
48716000000 usd
CY2024Q1 ci Insurance And Contractholder Liabilities Noncurrent
InsuranceAndContractholderLiabilitiesNoncurrent
10641000000 usd
CY2023Q4 ci Insurance And Contractholder Liabilities Noncurrent
InsuranceAndContractholderLiabilitiesNoncurrent
10904000000 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7029000000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7173000000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3653000000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3441000000 usd
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
31053000000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
28155000000 usd
CY2024Q1 us-gaap Separate Accounts Liability
SeparateAccountsLiability
7416000000 usd
CY2023Q4 us-gaap Separate Accounts Liability
SeparateAccountsLiability
7430000000 usd
CY2024Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
0 usd
CY2023Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
591000000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
111769000000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
106410000000 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
0 usd
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
107000000 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
4000000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
4000000 usd
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
30292000000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
30669000000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2324000000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1864000000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
40978000000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
41652000000 usd
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
27769000000 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
24238000000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
41181000000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
46223000000 usd
CY2024Q1 us-gaap Minority Interest
MinorityInterest
169000000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
21000000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
41350000000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
46244000000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
153119000000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
152761000000 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
402000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
400000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
46244000000 usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
107000000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
149000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-460000000 usd
CY2024Q1 ci Temporary Equity Other Comprehensive Income
TemporaryEquityOtherComprehensiveIncome
0 usd
CY2024Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-212000000 usd
CY2024Q1 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
0 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.40
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
397000000 usd
CY2024Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4057000000 usd
CY2024Q1 ci Noncontrolling Interest Other Changes
NoncontrollingInterestOtherChanges
83000000 usd
CY2024Q1 us-gaap Temporary Equity Other Changes
TemporaryEquityOtherChanges
-107000000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
41350000000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
958000000 usd
CY2023Q1 ci Noncontrolling Interest Other Changes
NoncontrollingInterestOtherChanges
-2000000 usd
CY2024Q1 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
0 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
66000000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-5000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-111000000 usd
CY2023Q1 ci Temporary Equity Other Comprehensive Income
TemporaryEquityOtherComprehensiveIncome
0 usd
CY2023Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
1272000000 usd
CY2023Q1 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
34000000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.23
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
366000000 usd
CY2023Q1 us-gaap Temporary Equity Other Changes
TemporaryEquityOtherChanges
-22000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
44518000000 usd
CY2023Q1 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
78000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-212000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1306000000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
741000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
749000000 usd
CY2024Q1 ci Realized Investment Gain Loss
RealizedInvestmentGainLoss
-1836000000 usd
CY2023Q1 ci Realized Investment Gain Loss
RealizedInvestmentGainLoss
-56000000 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
102000000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
108000000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-19000000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 usd
CY2024Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
2687000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
479000000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1015000000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-566000000 usd
CY2024Q1 us-gaap Increase Decrease In Reinsurance Recoverable
IncreaseDecreaseInReinsuranceRecoverable
-68000000 usd
CY2023Q1 us-gaap Increase Decrease In Reinsurance Recoverable
IncreaseDecreaseInReinsuranceRecoverable
-72000000 usd
CY2024Q1 us-gaap Increase Decrease In Insurance Liabilities
IncreaseDecreaseInInsuranceLiabilities
532000000 usd
CY2023Q1 us-gaap Increase Decrease In Insurance Liabilities
IncreaseDecreaseInInsuranceLiabilities
1533000000 usd
CY2024Q1 ci Increase Decrease In Pharmacy And Service Costs Payable
IncreaseDecreaseInPharmacyAndServiceCostsPayable
4637000000 usd
CY2023Q1 ci Increase Decrease In Pharmacy And Service Costs Payable
IncreaseDecreaseInPharmacyAndServiceCostsPayable
539000000 usd
CY2024Q1 ci Increase Decrease In Accounts Payable Accrued And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities
-1068000000 usd
CY2023Q1 ci Increase Decrease In Accounts Payable Accrued And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities
690000000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-61000000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-104000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4840000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5028000000 usd
CY2024Q1 ci Proceeds From Sale Of Debt And Equity Securities
ProceedsFromSaleOfDebtAndEquitySecurities
268000000 usd
CY2023Q1 ci Proceeds From Sale Of Debt And Equity Securities
ProceedsFromSaleOfDebtAndEquitySecurities
196000000 usd
CY2024Q1 ci Proceeds From Maturities Prepayments And Calls Of Debt And Equity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities
179000000 usd
CY2023Q1 ci Proceeds From Maturities Prepayments And Calls Of Debt And Equity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities
257000000 usd
CY2024Q1 us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
4000000 usd
CY2023Q1 us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
4000000 usd
CY2024Q1 us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
272000000 usd
CY2023Q1 us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
160000000 usd
CY2024Q1 ci Payments To Acquire Debt And Equity Securities
PaymentsToAcquireDebtAndEquitySecurities
180000000 usd
CY2023Q1 ci Payments To Acquire Debt And Equity Securities
PaymentsToAcquireDebtAndEquitySecurities
2794000000 usd
CY2024Q1 us-gaap Payments To Acquire Mortgage Notes Receivable
PaymentsToAcquireMortgageNotesReceivable
32000000 usd
CY2023Q1 us-gaap Payments To Acquire Mortgage Notes Receivable
PaymentsToAcquireMortgageNotesReceivable
0 usd
CY2024Q1 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
594000000 usd
CY2023Q1 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
377000000 usd
CY2024Q1 ci Payments For Proceeds From Property Plant And Equipment
PaymentsForProceedsFromPropertyPlantAndEquipment
300000000 usd
CY2023Q1 ci Payments For Proceeds From Property Plant And Equipment
PaymentsForProceedsFromPropertyPlantAndEquipment
408000000 usd
CY2024Q1 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
0 usd
CY2023Q1 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
22000000 usd
CY2024Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
112000000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
43000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-495000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2983000000 usd
CY2024Q1 us-gaap Additions To Contract Holders Funds
AdditionsToContractHoldersFunds
43000000 usd
CY2023Q1 us-gaap Additions To Contract Holders Funds
AdditionsToContractHoldersFunds
45000000 usd
CY2024Q1 us-gaap Withdrawal From Contract Holders Funds
WithdrawalFromContractHoldersFunds
65000000 usd
CY2023Q1 us-gaap Withdrawal From Contract Holders Funds
WithdrawalFromContractHoldersFunds
48000000 usd
CY2024Q1 ci Proceeds From Repayments Of Other Short Term Debt
ProceedsFromRepaymentsOfOtherShortTermDebt
-364000000 usd
CY2023Q1 ci Proceeds From Repayments Of Other Short Term Debt
ProceedsFromRepaymentsOfOtherShortTermDebt
-9000000 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2210000000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
80000000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
4462000000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1491000000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4022000000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
962000000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
181000000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
30000000 usd
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
401000000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
368000000 usd
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-153000000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-136000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2529000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-37000000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-9000000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1807000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2013000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8337000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5976000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10144000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7989000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
1660000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
0 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8484000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7989000000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
110000000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
77000000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
336000000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
322000000 usd
CY2024Q1 us-gaap Nature Of Operations
NatureOfOperations
<div style="margin-bottom:10pt"><span id="i794be1733ed749d0938dc64990bec2db_3556"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1 – Description of Business</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Cigna Group, together with its subsidiaries (either individually or collectively referred to as the "Company," "we," "us" or "our"), is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. Powered by our people and our brands, we advance our mission to improve the health and vitality of those we serve. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our subsidiaries offer a differentiated set of pharmacy, medical, behavioral, dental and related products and services. The majority of these products and services are offered through employers and other groups such as governmental and non-governmental organizations, unions and associations. Cigna Healthcare also offers health and dental insurance and Medicare products to individuals in the United States and selected international markets. In addition to these operations, The Cigna Group also has certain run-off operations.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A full description of our segments follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Evernorth Health Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> reportable segment now presents the Pharmacy Benefit Services and the Specialty and Care Services operating segments, which partner with health plans, employers, governmental organizations and health care providers to solve challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pharmacy Benefit Services drives high-quality, cost-effective pharmacy care through various services such as drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management and access to our home delivery pharmacy. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, as well as clinical programs to help our clients drive better whole-person health outcomes through Care Delivery and Management Solutions. The Company's reporting units remain aligned with its operating segments and goodwill was allocated on a relative fair value basis.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Cigna Healthcare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> reportable segment includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. U.S. Healthcare provides medical plans and specialty benefits and solutions for insured and self-insured clients, Medicare Advantage, Medicare Supplement and Medicare Stand-Alone Prescription Drug Plans for seniors and individual health insurance plans. International Health provides health care solutions in our international markets, as well as health care benefits for globally mobile individuals and employees of multinational organizations. </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In January 2024, the Company entered into a definitive agreement to sell the Medicare Advantage, Medicare Stand-Alone Prescription Drug Plans, Medicare and Other Supplemental Benefits and CareAllies businesses within the <span style="-sec-ix-hidden:f-355">U.S. Healthcare</span> operating segment to Health Care Service Corporation ("HCSC") for approximately $3.3 billion cash, subject to applicable regulatory approvals and other customary closing conditions (the "HCSC transaction"). See Note 5 to the Consolidated Financial Statements for further information.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Other Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> comprises the remainder of our business operations, which includes our continuing business (corporate-owned life insurance ("COLI")) and our run-off and other non-strategic businesses. Our run-off businesses include (i) variable annuity reinsurance business that was effectively exited through reinsurance with Berkshire Hathaway Life Insurance Company of Nebraska ("Berkshire") in 2013, (ii) settlement annuity business, and (iii) individual life insurance and annuity and retirement benefits businesses which were sold through reinsurance agreements.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">reflects amounts not allocated to operating segments, including net interest expense (defined as interest on corporate financing less net investment income on investments not supporting segment and other operations), certain litigation matters, expense associated with our frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs and eliminations for products and services sold between segments.</span></div>
CY2024Q1 ci Noninsurance Customer Receivables Excluding Pharmaceutical Manufacturers Receivable Before Reclassification To Disposal Group Assets Held For Sale
NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale
9735000000 usd
CY2023Q4 ci Noninsurance Customer Receivables Excluding Pharmaceutical Manufacturers Receivable Before Reclassification To Disposal Group Assets Held For Sale
NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale
8044000000 usd
CY2024Q1 ci Pharmaceutical Manufacturers Receivable Before Reclassification To Disposal Group Assets Held For Sale
PharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale
9512000000 usd
CY2023Q4 ci Pharmaceutical Manufacturers Receivable Before Reclassification To Disposal Group Assets Held For Sale
PharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale
8169000000 usd
CY2024Q1 ci Insurance Customer Receivables Before Reclassification To Disposal Group Assets Held For Sale
InsuranceCustomerReceivablesBeforeReclassificationToDisposalGroupAssetsHeldForSale
2045000000 usd
CY2023Q4 ci Insurance Customer Receivables Before Reclassification To Disposal Group Assets Held For Sale
InsuranceCustomerReceivablesBeforeReclassificationToDisposalGroupAssetsHeldForSale
2359000000 usd
CY2024Q1 ci Accounts And Other Receivables Net Current Before Reclassification To Disposal Group Assets Held For Sale
AccountsAndOtherReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale
230000000 usd
CY2023Q4 ci Accounts And Other Receivables Net Current Before Reclassification To Disposal Group Assets Held For Sale
AccountsAndOtherReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale
272000000 usd
CY2024Q1 ci Receivables Net Current Before Reclassification To Disposal Group Assets Held For Sale
ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale
21522000000 usd
CY2023Q4 ci Receivables Net Current Before Reclassification To Disposal Group Assets Held For Sale
ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale
18844000000 usd
CY2024Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
20563000000 usd
CY2023Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
17722000000 usd
CY2024Q1 ci Allowance For Receivables Current
AllowanceForReceivablesCurrent
4500000000 usd
CY2023Q4 ci Allowance For Receivables Current
AllowanceForReceivablesCurrent
3700000000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
91000000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
90000000 usd
CY2023Q3 ci Accounts Receivable Uncommitted Factoring Facility Total Capacity
AccountsReceivableUncommittedFactoringFacilityTotalCapacity
1000000000 usd
CY2023Q3 ci Accounts Receivable Uncommitted Factoring Facility Initial Term
AccountsReceivableUncommittedFactoringFacilityInitialTerm
P2Y
CY2023Q3 ci Accounts Receivable Uncommitted Factoring Facility Automatic Renewal Term
AccountsReceivableUncommittedFactoringFacilityAutomaticRenewalTerm
P1Y
CY2024Q1 ci Accounts Receivable Uncommitted Factoring Facility Amount Sold
AccountsReceivableUncommittedFactoringFacilityAmountSold
1900000000 usd
CY2024Q1 ci Accounts Receivable Uncommitted Factoring Facility Accounts Receivable Sold That Remain Outstanding
AccountsReceivableUncommittedFactoringFacilityAccountsReceivableSoldThatRemainOutstanding
93000000 usd
CY2024Q1 ci Accounts Receivable Uncommitted Factoring Facility Accounts Receivable Received But Not Remitted
AccountsReceivableUncommittedFactoringFacilityAccountsReceivableReceivedButNotRemitted
722000000 usd
CY2023Q4 ci Accounts Receivable Uncommitted Factoring Facility Accounts Receivable Received But Not Remitted
AccountsReceivableUncommittedFactoringFacilityAccountsReceivableReceivedButNotRemitted
515000000 usd
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3293000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3293000 shares
CY2024Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
286465000 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
286465000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
295706000 shares
CY2024Q1 us-gaap Supplier Finance Program Obligation Current
SupplierFinanceProgramObligationCurrent
1600000000 usd
CY2023Q4 us-gaap Supplier Finance Program Obligation Current
SupplierFinanceProgramObligationCurrent
1500000000 usd
CY2024Q1 ci Supplier Finance Program Outstanding Payment Obligation Current Voluntarily Elected To Be Sold
SupplierFinanceProgramOutstandingPaymentObligationCurrentVoluntarilyElectedToBeSold
327000000 usd
CY2024Q1 ci Transaction Related Costs
TransactionRelatedCosts
37000000 usd
CY2024Q1 ci Transaction Related Costs After Tax
TransactionRelatedCostsAfterTax
29000000 usd
CY2023Q1 ci Transaction Related Costs
TransactionRelatedCosts
1000000 usd
CY2023Q1 ci Transaction Related Costs After Tax
TransactionRelatedCostsAfterTax
1000000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-277000000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-277000000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1267000000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1267000000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
286465000 shares
CY2024Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
286465000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
295706000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
295706000 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3293000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
298999000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.97
CY2024Q1 ci Earnings Per Share Effect Of Dilution
EarningsPerShareEffectOfDilution
0
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.97
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.28
CY2023Q1 ci Earnings Per Share Effect Of Dilution
EarningsPerShareEffectOfDilution
-0.04
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.24
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8200000 shares
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
117800000 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
107400000 shares
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
102700000 shares
CY2024Q1 us-gaap Commercial Paper
CommercialPaper
884000000 usd
CY2023Q4 us-gaap Commercial Paper
CommercialPaper
1237000000 usd
CY2024Q1 ci Other Short Term Debt Current Maturities Of Long Term Debt And Lease Obligations Current
OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent
42000000 usd
CY2023Q4 ci Other Short Term Debt Current Maturities Of Long Term Debt And Lease Obligations Current
OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent
42000000 usd
CY2024Q1 us-gaap Debt Current
DebtCurrent
1715000000 usd
CY2023Q4 us-gaap Debt Current
DebtCurrent
2775000000 usd
CY2024Q1 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
59000000 usd
CY2023Q4 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
66000000 usd
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
31053000000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
28155000000 usd
CY2024Q1 srt Commercial Paper Average Rate Paid
CommercialPaperAverageRatePaid
0.0554
CY2024Q1 us-gaap Debt Instrument Repurchased Face Amount
DebtInstrumentRepurchasedFaceAmount
1800000000 usd
CY2024Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
369000000 usd
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
345000000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.40
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.23
CY2024Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.40
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
401000000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.23
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
368000000 usd
CY2024Q1 us-gaap Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense
ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's insurance and contractholder liabilities were comprised of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.048%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unpaid claims and claim expenses</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cigna Healthcare</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,786</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">77</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,863</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,017 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,092 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,959 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other Operations</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">99</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">161</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">260</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">154 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">253 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">272 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Future policy benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cigna Healthcare</span></div></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">92</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">515</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">607</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">518 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">615 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">601 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other Operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">163</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,297</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,460</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">163 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,375 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,538 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,631 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contractholder deposit funds</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cigna Healthcare</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">130</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">141</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">133 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">163 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other Operations</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">365</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6,087</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6,452</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">362 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,178 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,540 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,670 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Market risk benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">26</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">865</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">891</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">966 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,003 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,220 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unearned premiums</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">815</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">21</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">836</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">846 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">868 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,440 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,357</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11,153</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">18,510</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,633 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,421 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,054 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Insurance and contractholder liabilities classified as liabilities of businesses held for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,569)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(512)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(2,081)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,119)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(517)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,636)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total insurance and contractholder liabilities</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,788</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,641</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16,429</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,514 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,904 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,418 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,956 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"> Amounts classified as liabilities of businesses held for sale include $1,378 million of Unpaid claims, $427 million of Future policy benefits, $161 million of Unearned premiums and $115 million of Contractholder deposit funds as of March 31, 2024 and $823 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">of Unpaid claims, $429 million of Future policy benefits, $261 million of Unearned premiums and $123 million of Contractholder deposit funds as of December 31, 2023.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Activity, net of intercompany transactions, in the unpaid claims liability for the Cigna Healthcare segment was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.707%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,092</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,176 </span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Reinsurance and other amounts recoverable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">236</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">221 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance, net</span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,856</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,955 </span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incurred costs related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9,452</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,041 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(226)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(144)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9,226</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,897 </span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Paid costs related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,072</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,316 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,352</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,795 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,424</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,111 </span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,658</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,741 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Add: Reinsurance and other amounts recoverable</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">205</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">218 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,863</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,959 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"> Includes unpaid claims amounts classified as liabilities of businesses held for sale. As of March 31, 2024</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">and December 31, 2023, $1,378 million and $823 million classified as liabilities of businesses held for sale, respectively.</span></div>
CY2024Q1 ci Market Risk Benefit Liability Amount Current
MarketRiskBenefitLiabilityAmountCurrent
26000000 usd
CY2024Q1 ci Market Risk Benefit Liability Amount Noncurrent
MarketRiskBenefitLiabilityAmountNoncurrent
865000000 usd
CY2024Q1 us-gaap Market Risk Benefit Liability Amount
MarketRiskBenefitLiabilityAmount
891000000 usd
CY2023Q4 ci Market Risk Benefit Liability Amount Current
MarketRiskBenefitLiabilityAmountCurrent
37000000 usd
CY2023Q4 ci Market Risk Benefit Liability Amount Noncurrent
MarketRiskBenefitLiabilityAmountNoncurrent
966000000 usd
CY2023Q4 us-gaap Market Risk Benefit Liability Amount
MarketRiskBenefitLiabilityAmount
1003000000 usd
CY2023Q1 us-gaap Market Risk Benefit Liability Amount
MarketRiskBenefitLiabilityAmount
1220000000 usd
CY2024Q1 ci Unearned Premiums Current Including Disposal Groups
UnearnedPremiumsCurrentIncludingDisposalGroups
815000000 usd
CY2024Q1 ci Unearned Premiums Noncurrent Including Disposal Groups
UnearnedPremiumsNoncurrentIncludingDisposalGroups
21000000 usd
CY2024Q1 ci Unearned Premiums Including Disposal Groups
UnearnedPremiumsIncludingDisposalGroups
836000000 usd
CY2023Q4 ci Unearned Premiums Current Including Disposal Groups
UnearnedPremiumsCurrentIncludingDisposalGroups
846000000 usd
CY2023Q4 ci Unearned Premiums Noncurrent Including Disposal Groups
UnearnedPremiumsNoncurrentIncludingDisposalGroups
22000000 usd
CY2023Q4 ci Unearned Premiums Including Disposal Groups
UnearnedPremiumsIncludingDisposalGroups
868000000 usd
CY2023Q1 us-gaap Unearned Premiums
UnearnedPremiums
1440000000 usd
CY2024Q1 ci Insurance And Contractholder Liabilities Current Including Disposal Groups
InsuranceAndContractholderLiabilitiesCurrentIncludingDisposalGroups
7357000000 usd
CY2024Q1 ci Insurance And Contractholder Liabilities Noncurrent Including Disposal Groups
InsuranceAndContractholderLiabilitiesNoncurrentIncludingDisposalGroups
11153000000 usd
CY2024Q1 ci Insurance And Contractholder Liabilities Including Disposal Groups
InsuranceAndContractholderLiabilitiesIncludingDisposalGroups
18510000000 usd
CY2023Q4 ci Insurance And Contractholder Liabilities Current Including Disposal Groups
InsuranceAndContractholderLiabilitiesCurrentIncludingDisposalGroups
6633000000 usd
CY2023Q4 ci Insurance And Contractholder Liabilities Noncurrent Including Disposal Groups
InsuranceAndContractholderLiabilitiesNoncurrentIncludingDisposalGroups
11421000000 usd
CY2023Q4 ci Insurance And Contractholder Liabilities Including Disposal Groups
InsuranceAndContractholderLiabilitiesIncludingDisposalGroups
18054000000 usd
CY2024Q1 ci Insurance And Contractholder Liabilities Current
InsuranceAndContractholderLiabilitiesCurrent
5788000000 usd
CY2024Q1 ci Insurance And Contractholder Liabilities Noncurrent
InsuranceAndContractholderLiabilitiesNoncurrent
10641000000 usd
CY2024Q1 ci Insurance And Contractholder Liabilities
InsuranceAndContractholderLiabilities
16429000000 usd
CY2023Q4 ci Insurance And Contractholder Liabilities Current
InsuranceAndContractholderLiabilitiesCurrent
5514000000 usd
CY2023Q4 ci Insurance And Contractholder Liabilities Noncurrent
InsuranceAndContractholderLiabilitiesNoncurrent
10904000000 usd
CY2023Q4 ci Insurance And Contractholder Liabilities
InsuranceAndContractholderLiabilities
16418000000 usd
CY2023Q1 ci Insurance And Contractholder Liabilities
InsuranceAndContractholderLiabilities
18956000000 usd
CY2024Q1 ci Policyholder Contract Balance Percent Reinsured Externally
PolicyholderContractBalancePercentReinsuredExternally
0.38
CY2024Q1 ci Annuitization Election Period
AnnuitizationElectionPeriod
P30D
CY2023Q4 us-gaap Market Risk Benefit After Increase Decrease From Instrument Specific Credit Risk
MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk
1003000000 usd
CY2022Q4 us-gaap Market Risk Benefit After Increase Decrease From Instrument Specific Credit Risk
MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk
1268000000 usd
CY2023Q4 us-gaap Market Risk Benefit Before Reinsurance And Cumulative Increase Decrease From Instrument Specific Credit Risk Change
MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange
1085000000 usd
CY2022Q4 us-gaap Market Risk Benefit Before Reinsurance And Cumulative Increase Decrease From Instrument Specific Credit Risk Change
MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange
1379000000 usd
CY2024Q1 ci Market Risk Benefit Increase Decrease Due To Expected Run Off
MarketRiskBenefitIncreaseDecreaseDueToExpectedRunOff
-3000000 usd
CY2023Q1 ci Market Risk Benefit Increase Decrease Due To Expected Run Off
MarketRiskBenefitIncreaseDecreaseDueToExpectedRunOff
-6000000 usd
CY2024Q1 ci Market Risk Benefit Increase Decrease From Interest Rate Change And Equity Market Change
MarketRiskBenefitIncreaseDecreaseFromInterestRateChangeAndEquityMarketChange
-113000000 usd
CY2023Q1 ci Market Risk Benefit Increase Decrease From Interest Rate Change And Equity Market Change
MarketRiskBenefitIncreaseDecreaseFromInterestRateChangeAndEquityMarketChange
-41000000 usd
CY2024Q1 us-gaap Market Risk Benefit Increase Decrease From Actual Policyholder Behavior Different From Expected
MarketRiskBenefitIncreaseDecreaseFromActualPolicyholderBehaviorDifferentFromExpected
-14000000 usd
CY2023Q1 us-gaap Market Risk Benefit Increase Decrease From Actual Policyholder Behavior Different From Expected
MarketRiskBenefitIncreaseDecreaseFromActualPolicyholderBehaviorDifferentFromExpected
6000000 usd
CY2024Q1 us-gaap Market Risk Benefit Increase Decrease From Other Assumption
MarketRiskBenefitIncreaseDecreaseFromOtherAssumption
0 usd
CY2023Q1 us-gaap Market Risk Benefit Increase Decrease From Other Assumption
MarketRiskBenefitIncreaseDecreaseFromOtherAssumption
-33000000 usd
CY2024Q1 us-gaap Market Risk Benefit Before Reinsurance And Cumulative Increase Decrease From Instrument Specific Credit Risk Change
MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange
955000000 usd
CY2023Q1 us-gaap Market Risk Benefit Before Reinsurance And Cumulative Increase Decrease From Instrument Specific Credit Risk Change
MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange
1305000000 usd
CY2024Q1 us-gaap Aoci Market Risk Benefit Instrument Specific Credit Risk Before Tax
AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax
64000000 usd
CY2023Q1 us-gaap Aoci Market Risk Benefit Instrument Specific Credit Risk Before Tax
AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax
85000000 usd
CY2024Q1 us-gaap Market Risk Benefit After Increase Decrease From Instrument Specific Credit Risk
MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk
891000000 usd
CY2023Q1 us-gaap Market Risk Benefit After Increase Decrease From Instrument Specific Credit Risk
MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk
1220000000 usd
CY2024Q1 us-gaap Market Risk Benefit Reinsurance Recoverable After Allowance
MarketRiskBenefitReinsuranceRecoverableAfterAllowance
951000000 usd
CY2023Q1 us-gaap Market Risk Benefit Reinsurance Recoverable After Allowance
MarketRiskBenefitReinsuranceRecoverableAfterAllowance
1301000000 usd
CY2024Q1 ci Reinsurance Recoverables Gross Before Reclassification To Disposal Group Assets Held For Sale
ReinsuranceRecoverablesGrossBeforeReclassificationToDisposalGroupAssetsHeldForSale
4131000000 usd
CY2024Q1 ci Reinsurance Recoverable Allowance For Credit Loss Before Reclassification To Disposal Group Assets Held For Sale
ReinsuranceRecoverableAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale
35000000 usd
CY2024Q1 ci Reinsurance Recoverables Including Reinsurance Premium Paid Before Reclassification To Disposal Group Assets Held For Sale
ReinsuranceRecoverablesIncludingReinsurancePremiumPaidBeforeReclassificationToDisposalGroupAssetsHeldForSale
5047000000 usd
CY2024Q1 ci Short Term Investments Before Reclassification To Disposal Group Assets Held For Sale
ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale
1193000000 usd
CY2024Q1 ci Long Term Investments Before Reclassification To Disposal Group Assets Held For Sale
LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale
17281000000 usd
CY2024Q1 ci Investments Before Reclassification To Disposal Group Assets Held For Sale
InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale
18474000000 usd
CY2023Q4 ci Short Term Investments Before Reclassification To Disposal Group Assets Held For Sale
ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale
1009000000 usd
CY2023Q4 ci Long Term Investments Before Reclassification To Disposal Group Assets Held For Sale
LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale
19339000000 usd
CY2023Q4 ci Investments Before Reclassification To Disposal Group Assets Held For Sale
InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale
20348000000 usd
CY2024Q1 us-gaap Short Term Investments
ShortTermInvestments
1108000000 usd
CY2024Q1 us-gaap Long Term Investments
LongTermInvestments
16025000000 usd
CY2024Q1 us-gaap Investments
Investments
17133000000 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
925000000 usd
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
17985000000 usd
CY2023Q4 us-gaap Investments
Investments
18910000000 usd
CY2024Q1 ci Debt Securities Available For Sale Amortized Cost Maturity Allocated And Single Maturity Date Year One Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleAmortizedCostMaturityAllocatedAndSingleMaturityDateYearOneBeforeReclassificationToDisposalGroupAssetsHeldForSale
633000000 usd
CY2024Q1 ci Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date Year One Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateYearOneBeforeReclassificationToDisposalGroupAssetsHeldForSale
619000000 usd
CY2024Q1 ci Debt Securities Available For Sale Amortized Cost Maturity Allocated And Single Maturity Date After Year One Through Five Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFiveBeforeReclassificationToDisposalGroupAssetsHeldForSale
3768000000 usd
CY2024Q1 ci Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Year One Through Five Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFiveBeforeReclassificationToDisposalGroupAssetsHeldForSale
3587000000 usd
CY2024Q1 ci Debt Securities Available For Sale Amortized Cost Maturity Allocated And Single Maturity Date After Year5 Through10 Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYear5Through10BeforeReclassificationToDisposalGroupAssetsHeldForSale
3144000000 usd
CY2024Q1 ci Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Year5 Through10 Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYear5Through10BeforeReclassificationToDisposalGroupAssetsHeldForSale
2921000000 usd
CY2024Q1 ci Debt Securities Available For Sale Amortized Cost Maturity Allocated And Single Maturity Date After Year10 Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYear10BeforeReclassificationToDisposalGroupAssetsHeldForSale
2186000000 usd
CY2024Q1 ci Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Year10 Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYear10BeforeReclassificationToDisposalGroupAssetsHeldForSale
2000000000 usd
CY2024Q1 ci Debt Securities Available For Sale Maturity Without Single Maturity Date Amortized Cost Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleMaturityWithoutSingleMaturityDateAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale
389000000 usd
CY2024Q1 ci Debt Securities Available For Sale Maturity Without Single Maturity Date Fair Value Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleMaturityWithoutSingleMaturityDateFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale
353000000 usd
CY2024Q1 ci Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale
10120000000 usd
CY2024Q1 ci Debt Securities Available For Sale Excluding Accrued Interest Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleExcludingAccruedInterestBeforeReclassificationToDisposalGroupAssetsHeldForSale
9480000000 usd
CY2024Q1 ci Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale
10120000000 usd
CY2024Q1 ci Debt Securities Available For Sale Allowance For Credit Loss Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale
50000000 usd
CY2024Q1 ci Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax Before Reclassification To Disposal Group Assets Held For Sale
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale
153000000 usd
CY2024Q1 ci Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax Before Reclassification To Disposal Group Assets Held For Sale
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale
743000000 usd
CY2024Q1 ci Debt Securities Available For Sale Excluding Accrued Interest Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleExcludingAccruedInterestBeforeReclassificationToDisposalGroupAssetsHeldForSale
9480000000 usd
CY2023Q4 ci Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale
10379000000 usd
CY2023Q4 ci Debt Securities Available For Sale Allowance For Credit Loss Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale
33000000 usd
CY2023Q4 ci Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax Before Reclassification To Disposal Group Assets Held For Sale
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale
195000000 usd
CY2023Q4 ci Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax Before Reclassification To Disposal Group Assets Held For Sale
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale
686000000 usd
CY2023Q4 ci Debt Securities Available For Sale Excluding Accrued Interest Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleExcludingAccruedInterestBeforeReclassificationToDisposalGroupAssetsHeldForSale
9855000000 usd
CY2024Q1 ci Debt Securities Available For Sale Unrealized Loss Position Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale
6577000000 usd
CY2024Q1 ci Debt Securities Available For Sale Unrealized Loss Position Amortized Cost Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale
7320000000 usd
CY2024Q1 ci Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale
743000000 usd
CY2024Q1 ci Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Before Reclassification To Disposal Group Assets Held For Sale
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale
2413 position
CY2023Q4 ci Debt Securities Available For Sale Unrealized Loss Position Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale
6633000000 usd
CY2023Q4 ci Debt Securities Available For Sale Unrealized Loss Position Amortized Cost Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale
7319000000 usd
CY2023Q4 ci Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale
686000000 usd
CY2023Q4 ci Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Before Reclassification To Disposal Group Assets Held For Sale
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale
2353 position
CY2024Q1 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
647000000 usd
CY2024Q1 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
39000000 usd
CY2023Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
656000000 usd
CY2023Q4 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
51000000 usd
CY2024Q1 ci Equity Securities Without Readily Determinable Fair Value Amortized Cost
EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost
3281000000 usd
CY2024Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
1532000000 usd
CY2023Q4 ci Equity Securities Without Readily Determinable Fair Value Amortized Cost
EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost
3248000000 usd
CY2023Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
3311000000 usd
CY2024Q1 ci Equity Securities Fvni And Without Readily Determinable Fair Value And Hybrid Instruments Amortized Cost
EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost
3928000000 usd
CY2024Q1 ci Equity Securities Fvni And Without Readily Determinable Fair Value And Hybrid Instruments Carrying Amount
EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount
1571000000 usd
CY2023Q4 ci Equity Securities Fvni And Without Readily Determinable Fair Value And Hybrid Instruments Amortized Cost
EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost
3904000000 usd
CY2023Q4 ci Equity Securities Fvni And Without Readily Determinable Fair Value And Hybrid Instruments Carrying Amount
EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount
3362000000 usd
CY2024Q1 ci Other Long Term Investments Before Reclassification To Disposal Group Assets Held For Sale
OtherLongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale
4301000000 usd
CY2023Q4 ci Other Long Term Investments Before Reclassification To Disposal Group Assets Held For Sale
OtherLongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale
4181000000 usd
CY2024Q1 ci Realized Investment Gain Loss
RealizedInvestmentGainLoss
-1836000000 usd
CY2023Q1 ci Realized Investment Gain Loss
RealizedInvestmentGainLoss
-56000000 usd
CY2024Q1 ci Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Unrealized Gain Loss Included In Other Comprehensive Income Loss
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss
-4000000 usd
CY2023Q1 ci Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Unrealized Gain Loss Included In Other Comprehensive Income Loss
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss
5000000 usd
CY2024Q1 ci Guaranteed Separate Account Assets
GuaranteedSeparateAccountAssets
569000000 usd
CY2023Q4 ci Guaranteed Separate Account Assets
GuaranteedSeparateAccountAssets
578000000 usd
CY2024Q1 ci Non Guaranteed Separate Account Assets Classified In Fair Value Hierarchy
NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy
6181000000 usd
CY2023Q4 ci Non Guaranteed Separate Account Assets Classified In Fair Value Hierarchy
NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy
6172000000 usd
CY2024Q1 ci Separate Account Assets Classified In Fair Value Hierarchy
SeparateAccountAssetsClassifiedInFairValueHierarchy
6750000000 usd
CY2023Q4 ci Separate Account Assets Classified In Fair Value Hierarchy
SeparateAccountAssetsClassifiedInFairValueHierarchy
6750000000 usd
CY2024Q1 ci Non Guaranteed Separate Account Assets Priced At Net Asset Value As A Practical Expedient
NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient
666000000 usd
CY2023Q4 ci Non Guaranteed Separate Account Assets Priced At Net Asset Value As A Practical Expedient
NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient
680000000 usd
CY2024Q1 us-gaap Separate Account Assets
SeparateAccountAssets
7416000000 usd
CY2023Q4 us-gaap Separate Account Assets
SeparateAccountAssets
7430000000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
3.684
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.184
CY2024Q1 ci Deferred Tax Assets Investments Subject To Federal Capital Loss Utilization Rules
DeferredTaxAssetsInvestmentsSubjectToFederalCapitalLossUtilizationRules
664000000 usd
CY2024Q1 ci Deferred Tax Assets Valuation Allowance Investments Subject To Federal Capital Loss Utilization Rules
DeferredTaxAssetsValuationAllowanceInvestmentsSubjectToFederalCapitalLossUtilizationRules
427000000 usd
CY2024Q1 us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:8.28pt;text-decoration:underline">Financial Guarantees: Retiree and Life Insurance Benefits</span>The Company guarantees that separate account assets will be sufficient to pay certain life insurance or retiree benefits. For the majority of these benefits, the sponsoring employers are primarily responsible for ensuring that assets are sufficient to pay these benefits and are required to maintain assets that exceed a certain percentage of benefit obligations. If employers fail to do so, the Company or an affiliate of the buyer of the retirement benefits business has the right to redirect the management of the related assets to provide for benefit payments.An additional liability is established if management believes that the Company will be required to make payments under the guarantees;Separate account assets supporting these guarantees are classified in Levels 1 and 2 of the GAAP fair value hierarchy.<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:8.84pt;text-decoration:underline">Certain Other Guarantees</span>The Company had indemnification obligations as of March 31, 2024 in connection with acquisition and disposition transactions. These indemnification obligations are triggered by the breach of representations or covenants provided by the Company, such as representations for the presentation of financial statements, filing of tax returns, compliance with laws or regulations or identification of outstanding litigation. These obligations are typically subject to various time limitations, defined by the contract or by operation of law, such as statutes of limitation. In some cases, the maximum potential amount due is subject to contractual limitations based on a stated dollar amount or a percentage of the transaction purchase price, while in other cases limitations are not specified or applicable. The Company does not believe that it is possible to determine the maximum potential amount due under these obligations because not all amounts due under these indemnification obligations are subject to limitation.<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:8.28pt;text-decoration:underline">Guaranty Fund Assessments</span><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company operates in a regulatory environment that may require its participation in assessments under state insurance guaranty association laws. The Company's exposure to assessments for certain obligations of insolvent insurance companies to policyholders and claimants is based on its share of business written in the relevant jurisdictions.</span></div>
CY2024Q1 ci Transaction Related Costs
TransactionRelatedCosts
37000000 usd
CY2024Q1 ci Transaction Related Costs After Tax
TransactionRelatedCostsAfterTax
29000000 usd
CY2023Q1 ci Transaction Related Costs
TransactionRelatedCosts
1000000 usd
CY2023Q1 ci Transaction Related Costs After Tax
TransactionRelatedCostsAfterTax
1000000 usd
CY2024Q1 ci Special Item Gain Loss On Sale Of Business Before Taxes
SpecialItemGainLossOnSaleOfBusinessBeforeTaxes
-19000000 usd
CY2024Q1 ci Special Item Gain Loss On Sale Of Business Net Of Tax
SpecialItemGainLossOnSaleOfBusinessNetOfTax
43000000 usd
CY2023Q1 ci Special Item Gain Loss On Sale Of Business Before Taxes
SpecialItemGainLossOnSaleOfBusinessBeforeTaxes
0 usd
CY2023Q1 ci Special Item Gain Loss On Sale Of Business Net Of Tax
SpecialItemGainLossOnSaleOfBusinessNetOfTax
0 usd
CY2024Q1 ci Special Item Charge Benefit Tax Matters
SpecialItemChargeBenefitTaxMatters
0 usd
CY2024Q1 ci Special Item Charge Benefit Tax Matters After Tax
SpecialItemChargeBenefitTaxMattersAfterTax
17000000 usd
CY2023Q1 ci Special Item Charge Benefit Tax Matters
SpecialItemChargeBenefitTaxMatters
0 usd
CY2023Q1 ci Special Item Charge Benefit Tax Matters After Tax
SpecialItemChargeBenefitTaxMattersAfterTax
0 usd
CY2024Q1 ci Special Item Gain Or Loss Before Tax Attributable To Reportng Entity
SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity
-56000000 usd
CY2024Q1 ci Special Item Gain Or Loss Net Of Tax Attributable To Reportng Entity
SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity
-3000000 usd
CY2023Q1 ci Special Item Gain Or Loss Before Tax Attributable To Reportng Entity
SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity
-1000000 usd
CY2023Q1 ci Special Item Gain Or Loss Net Of Tax Attributable To Reportng Entity
SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity
-1000000 usd
CY2024Q1 ci Non Investment Revenue
NonInvestmentRevenue
56965000000 usd
CY2024Q1 us-gaap Net Investment Income
NetInvestmentIncome
290000000 usd
CY2024Q1 us-gaap Revenues
Revenues
57255000000 usd
CY2024Q1 ci Realized Investment Gains Losses Equity Method Investments
RealizedInvestmentGainsLossesEquityMethodInvestments
8000000 usd
CY2024Q1 ci Segment Revenues
SegmentRevenues
57247000000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
79000000 usd
CY2024Q1 ci Income Loss Attributable To Noncontrolling Interest Before Tax
IncomeLossAttributableToNoncontrollingInterestBeforeTax
77000000 usd
CY2024Q1 ci Realized Investment Gain Loss Including Equity Method Subsidiaries
RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries
-1828000000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
423000000 usd
CY2024Q1 ci Transaction Related Costs
TransactionRelatedCosts
37000000 usd
CY2024Q1 ci Special Item Gain Loss On Sale Of Business Before Taxes
SpecialItemGainLossOnSaleOfBusinessBeforeTaxes
-19000000 usd
CY2024Q1 ci Adjusted Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2309000000 usd
CY2023Q1 ci Non Investment Revenue
NonInvestmentRevenue
46240000000 usd
CY2023Q1 us-gaap Net Investment Income
NetInvestmentIncome
277000000 usd
CY2023Q1 us-gaap Revenues
Revenues
46517000000 usd
CY2023Q1 ci Realized Investment Gains Losses Equity Method Investments
RealizedInvestmentGainsLossesEquityMethodInvestments
38000000 usd
CY2023Q1 ci Segment Revenues
SegmentRevenues
46479000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1601000000 usd
CY2023Q1 ci Income Loss Attributable To Noncontrolling Interest Before Tax
IncomeLossAttributableToNoncontrollingInterestBeforeTax
43000000 usd
CY2023Q1 ci Realized Investment Gain Loss Including Equity Method Subsidiaries
RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries
-18000000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
459000000 usd
CY2023Q1 ci Transaction Related Costs
TransactionRelatedCosts
1000000 usd
CY2023Q1 ci Adjusted Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2036000000 usd
CY2024Q1 us-gaap Premiums Earned Net
PremiumsEarnedNet
11603000000 usd
CY2023Q1 us-gaap Premiums Earned Net
PremiumsEarnedNet
11025000000 usd
CY2024Q1 ci Non Investment Revenue
NonInvestmentRevenue
56965000000 usd
CY2023Q1 ci Non Investment Revenue
NonInvestmentRevenue
46240000000 usd
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001739940-24-000015-index-headers.html Edgar Link pending
0001739940-24-000015-index.html Edgar Link pending
0001739940-24-000015.txt Edgar Link pending
0001739940-24-000015-xbrl.zip Edgar Link pending
ci-20240331.htm Edgar Link pending
ci-20240331.xsd Edgar Link pending
ci-20240331_g1.jpg Edgar Link pending
exh_311x24q1.htm Edgar Link pending
exh_312x24q1.htm Edgar Link pending
exh_321x24q1.htm Edgar Link pending
exh_322x24q1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
ci-20240331_def.xml Edgar Link unprocessable
ci-20240331_lab.xml Edgar Link unprocessable
ci-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ci-20240331_htm.xml Edgar Link completed
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ci-20240331_cal.xml Edgar Link unprocessable